Cerebrovascular Complications in Patients with Left‐Sided Infective Endocarditis Are Common: A Prospective Study Using Magnetic Resonance Imaging and Neurochemical Brain Damage Markers
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Background. @nbsp; Cerebrovascular complications (CVCs) have remained a major therapeutic and prognostic challenge associated with infective endocarditis, and definite risk factors have not been fully elucidated. This prospective study was designed to the evaluate the total incidence of CVC associated with infective endocarditis and major risk factors. Methods. @nbsp; During 2 study periods, from June 1998 through April 2001 and from September 2002 through January 2005, patients were prospectively enrolled in the study regardless of neurological symptoms. Study patients underwent neurological examinations and magnetic resonance imaging of the brain, and cerebrospinal fluid analyses of inflammatory and neurochemical markers of brain damage (neurofilament protein and glial fibrillary acidic protein) were performed. Results. @nbsp; Sixty patients who experienced episodes of left-sided infective endocarditis were evaluated; 35% of these patients experienced a symptomatic CVC. Silent cerebral complications were detected in another 30% of the patients, and the total CVC rate was 65% (95% confidence interval, 58%-72%). Five percent of patients experienced their first neurological symptom after the initiation of antibiotic treatment without prior surgery. No new symptomatic CVCs were detected after 10 days of antibiotic treatment. No neurological deterioration was observed after surgery in patients who were established to have a symptomatic CVC preoperatively. A larger heart valvular vegetation size was a risk factor for both symptomatic and silent CVCs; Staphylococcus aureus etiology conferred a higher risk for symptomatic cerebral complication only. Conclusions. @nbsp; The use of sensitive methods of detection indicates that the incidence of CVC associated with infective endocarditis is high, but the risk for neurological deterioration during cardiac surgery after a CVC is lower than previously assumed. The major mechanism behind cerebral complications associated with infective endocarditis is cerebral embolization, although the dominant neurological symptoms vary considerably.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856 · cited 1×
“The area under the receiver operating characteristic curve equals the probability that a randomly chosen individual with a certain risk factor will have a higher value of the discriminating variable than will a randomly chosen individual without the risk factor [17, 18].”
BackgroundHosmer, D. W., & Lemeshow, S. (2000) · doi:10.1002/0471722146 · Cited by 20,302
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027 · cited 1×
“Of the 63 patients initially included in the study, 2 were later excluded according to the modified Duke criteria [19], and 1 withdrew from the study.”
MethodThuny, F., Disalvo, G., Belliard, O., Avierinos, J.-F., Pergola, V., Rosenberg, V., Casalta, J.-P., Gouvernet, J., Derumeaux, G., Iarussi, D., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.493155 · Cited by 703 · cited 1×
“aureus as the causative agent of infective endocarditis have been documented as risk factors for cerebral emboli in several recent studies [20, 30, 39, 40]; these risk factors were also observed in our study, but having a previous CVC was not a statistically significant risk factor.”
Good, P. (2000) · Springer Series in Statistics · doi:10.1007/978-1-4757-3235-1 · Cited by 573
Rosengren, L. E., Karlsson, J., Karlsson, J., Persson, L. I., & Wikkelsø, C. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67052013.x · Cited by 499
Self-citationEchocardiography predicts embolic events in infective endocarditis
Di Salvo, G., Habib, G., Pergola, V., Avierinos, J.-F., Philip, E., Casalta, J.-P., Vailloud, J.-M., Derumeaux, G., Gouvernet, J., Ambrosi, P., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01206-7 · Cited by 457 · cited 1×
“aureus as the causative agent of infective endocarditis have been documented as risk factors for cerebral emboli in several recent studies [20, 30, 39, 40]; these risk factors were also observed in our study, but having a previous CVC was not a statistically significant risk factor.”
Early Predictors of In-Hospital Death in Infective Endocarditis
Chu, V. H., Cabell, C. H., Benjamin, D. K., Kuniholm, E. F., Fowler, V. G., Engemann, J., Sexton, D. J., Corey, G. R., & Wang, A. (2004) · Circulation · doi:10.1161/01.cir.0000124719.61827.7f · Cited by 429
NEUROLOGIC COMPLICATIONS OF BACTERIAL ENDOCARDITIS
PRUITT, A. A., RUBIN, R. H., KARCHMER, A. W., & DUNCAN, G. W. (1978) · Medicine · doi:10.1097/00005792-197807000-00004 · Cited by 419
Research works printed but not linked: 2
- Piper C, 2001, J Heart Valve Dis, 10, 703
- Balasubramanian SK, 2005, J Heart Valve Dis, 14, 15
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
“Different studies including systematic cerebral MRI during acute IE have consistently reported frequent lesions, in 60–80% of patients.(83) Regardless of neurological symptoms, most abnormalities are ischaemic lesions (in 50–80% of patients), with more frequent small ischaemic lesions than larger territorial infarcts.”
Self-citationOtto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,905
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000932 · Cited by 2,449
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.018 · Cited by 1,982
2023 ESC Guidelines for the management of endocarditis
Delgado, V., Ajmone Marsan, N., de Waha, S., Bonaros, N., Brida, M., Burri, H., Caselli, S., Doenst, T., Ederhy, S., Erba, P. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad193 · Cited by 1,754
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.035 · Cited by 1,075
2014 AHA/ACC guideline for the management of patients with valvular heart disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.05.014 · Cited by 989
García-Cabrera, E., Fernández-Hidalgo, N., Almirante, B., Ivanova-Georgieva, R., Noureddine, M., Plata, A., Lomas, J. M., Gálvez-Acebal, J., Hidalgo-Tenorio, C., Ruíz-Morales, J., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000813 · Cited by 546
“Age, y <70 927 (69) 699 (75) 228 (25) ≥70 418 (31) 245 (59) 173 (41)† 1.”
InfluentialManagement of infective endocarditis: challenges and perspectives
Thuny, F., Grisoli, D., Collart, F., Habib, G., & Raoult, D. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60755-1 · Cited by 437
Holland, T. L., Baddour, L. M., Bayer, A. S., Hoen, B., Miro, J. M., & Fowler, V. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.59 · Cited by 406
Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism
Saric, M., Armour, A. C., Arnaout, M. S., Chaudhry, F. A., Grimm, R. A., Kronzon, I., Landeck, B. F., Maganti, K., Michelena, H. I., & Tolstrup, K. (2016) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2015.09.011 · Cited by 427
Pettersson, G. B., Coselli, J. S., Pettersson, G. B., Coselli, J. S., Hussain, S. T., Griffin, B., Blackstone, E. H., Gordon, S. M., LeMaire, S. A., & Woc-Colburn, L. E. (2017) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.09.093 · Cited by 410
Pathogenesis and treatment concepts of orthopaedic biofilm infections
Zimmerli, W., & Moser, C. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00938.x · Cited by 343
Duval, X., Iung, B., Klein, I., Brochet, E., Thabut, G., Arnoult, F., Lepage, L., Laissy, J.-P., Wolff, M., Leport, C., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-8-201004200-00006 · Cited by 289
“Previous studies that used brain CT or MRI in acute endocarditis (7, 12) were not designed to assess the changes in diagnostic classification and clinical management due to MRI.”
BackgroundMethodInfluentialMechanisms of infective endocarditis: pathogen–host interaction and risk states
Werdan, K., Dietz, S., Löffler, B., Niemann, S., Bushnaq, H., Silber, R.-E., Peters, G., & Müller-Werdan, U. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.174 · Cited by 283
2020 ACC/AHA guideline for the management of patients with valvular heart disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.002 · Cited by 279
Cardiac imaging in infectious endocarditis
Bruun, N. E., Habib, G., Thuny, F., & Sogaard, P. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht274 · Cited by 222
“By systematic use of MRI, cerebral lesions have been demonstrated in as many as 82% of IE patients,(42) and subclinical cerebrovascular events have been found in 30–40% of IE patients.(43)”
BackgroundSonneville, R., Mirabel, M., Hajage, D., Tubach, F., Vignon, P., Perez, P., Lavoué, S., Kouatchet, A., Pajot, O., Dessap, A. M., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182120b41 · Cited by 202
“Although the true rate of neurologic complications may have been underestimated, previously reported results showed that the impact of silent neurologic events on outcome was low (7, 9).”
BackgroundResultInfluentialPrediction of Symptomatic Embolism in Infective Endocarditis
Hubert, S., Thuny, F., Resseguier, N., Giorgi, R., Tribouilloy, C., Le Dolley, Y., Casalta, J.-P., Riberi, A., Chevalier, F., Rusinaru, D., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.029 · Cited by 185
“of patients with infective endocarditis (1-5).”
JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis
Nakatani, S., Ohara, T., Ashihara, K., Izumi, C., Iwanaga, S., Eishi, K., Okita, Y., Daimon, M., Kimura, T., Toyoda, K., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0549 · Cited by 179
Li, M., Kim, J. B., Sastry, B. K. S., & Chen, M. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01098-5 · Cited by 169
2015 ESC Guidelines for the management of infective endocarditis
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · Kardiologia Polska · doi:10.5603/kp.2015.0227 · Cited by 165
Self-citationBarsic, B., Dickerman, S., Krajinovic, V., Pappas, P., Altclas, J., Carosi, G., Casabé, J. H., Chu, V. H., Delahaye, F., Edathodu, J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis878 · Cited by 157
“[15–18].”
Self-citationMcDonald, J. R. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.04.013 · Cited by 172
“The risk of central nervous system embolism declines after initiation of antimicrobial therapy.(102,103) In a prospective study of 1437 patients with left-sided IE at 61 medical centers, the risk of central nervous system embolism declined by 65% between the first and second week of antibiotics.”
Brain MRI Findings in Neurologically Asymptomatic Patients with Infective Endocarditis
Hess, A., Klein, I. F., Iung, B., Lavallée, P. C., Ilic-Habensus, E., Dornic, Q., Arnoult, F., Mimoun, L., Wolff, M., Duval, X., et al. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3582 · Cited by 169
“Although none of the patients had undergone brain MR imaging before the onset of IE, different circumstances suggest a causal relationship between CMBs and IE.”
BackgroundInfluentialEndocarditis and Intravascular Infections
Fowler, V. G., Scheld, W. M., & Bayer, A. S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00082-5 · Cited by 152
Staphylococcus aureusbacteraemia and endocarditis – epidemiology and outcome: a review
Ásgeirsson, H., Thalme, A., & Weiland, O. (2017) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2017.1392039 · Cited by 163
Cerebral Microbleeds Are Frequent in Infective Endocarditis: A Case-Control Study
Klein, I. F., Iung, B., Labreuche, J., Hess, A., Wolff, M., Messika–Zeitoun, D., Lavallée, P. C., Laissy, J., Leport, C., Duval, X., et al. (2009) · Stroke · doi:10.1161/strokeaha.109.562546 · Cited by 108
Morris, N. A., Matiello, M., Lyons, J. L., & Samuels, M. A. (2014) · The Neurohospitalist · doi:10.1177/1941874414537077 · Cited by 127
“In prosthetic valve endocarditis, we usually convert patients from oral anticoagulants to IV heparin immediately with lower intensity than in patients without IE.”
Influentialand Investigators of the Italian Study on Endocarditis, Rizzi, M., Ravasio, V., Carobbio, A., Mattucci, I., Crapis, M., Stellini, R., Pasticci, M. B., Chinello, P., Falcone, M., et al. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-230 · Cited by 113
“Small, clinically inapparent emboli probably occur in most patients who have IE, as demonstrated with positron-emission tomography and magnetic resonance imaging; silent cerebrovascular complications (including ischemia and microhemorrhage) may occur in up to 81% of patients [9-11].”
Yanagawa, B., Pettersson, G., Habib, G., Ruel, M., Saposnik, G., Latter, D. A., & Verma, S. (2016) · Circulation · doi:10.1161/circulationaha.116.024156 · Cited by 106
Galar, A., Weil, A. A., Dudzinski, D. M., Muñóz, P., & Siedner, M. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00041-18 · Cited by 103
Infective Endocarditis: The European Viewpoint
Tornos, P., González‐Alujas, T., Thuny, F., & Habib, G. (2011) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2011.03.004 · Cited by 102
Infective Endocarditis: Prevention, Diagnosis, and Management
Thuny, F., Grisoli, D., Cautela, J., Ribéri, A., Raoult, D., & Habib, G. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.03.042 · Cited by 103
Iung, B., Tubiana, S., Klein, I. F., Messika–Zeitoun, D., Brochet, É., Lepage, L., Al‐Attar, N., Ruimy, R., Leport, C., Wolff, M., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.001470 · Cited by 98
“computed tomography (CT)(4-5) or cerebral magnetic resonance imaging (MRI).(8-10) Using”
BackgroundMethodInfective Endocarditis at Autopsy: A Review of Pathologic Manifestations and Clinical Correlates
Guerrero, M. L. F., Álvarez, B., Manzarbeitia, F., & Renedo, G. (2012) · Medicine · doi:10.1097/md.0b013e31825631ea · Cited by 98
“Symptomatic central nervous system complications have been found in 17%Y35% of cases of IE.36,46,69 Using MRI and neurochemical markers of brain damage, brain emboli have been detected in 65%Y80% of cases.20,69 The incidence of brain emboli is higher in patients with S. aureus endocarditis.20,25 As expected, infarcts…”
BackgroundInfluentialImpact of stroke on therapeutic decision making in infective endocarditis
Derex, L., Bonnefoy‐Cudraz, E., & Delahaye, F. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5364-3 · Cited by 86
“The decision to practice surgery in emergency in case of IE complicated by stroke rests upon the prevention of the IE’s risk of progression: cardiac valve destruction, progression to perivalvular abscess, uncontrolled infection (positive hemocultures after a week under antibiotic therapy), persistent vegetation[10 mm…”
InfluentialGoulenok, T. M., Klein, I. F., Mazighi, M., Messika–Zeitoun, D., Alexandra, J. F., Mourvillier, B., Laissy, J., Leport, C., Iung, B., Duval, X., et al. (2013) · Cerebrovascular Diseases · doi:10.1159/000348317 · Cited by 91
Infective endocarditis: innovations in the management of an old disease
Iung, B., & Duval, X. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0215-0 · Cited by 95
Yoshioka, D., Sakaguchi, T., Yamauchi, T., Okazaki, S., Miyagawa, S., Nishi, H., Yoshikawa, Y., Fukushima, S., Saito, S., & Sawa, Y. (2012) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2012.04.027 · Cited by 80
“Some studies have reported that the risk of CI deterioration during cardiac operations after a stroke may be lower than previously assumed, even in the acute phase of CI, except in patients with ICH [5, 6, 9].”
BackgroundResultCurrent Challenges in the Management of Infective Endocarditis
Cuervo, G., Escrihuela-Vidal, F., Gudiol, C., & Carratalà, J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.641243 · Cited by 88
“Clinically silent complications of the central nervous system, such as embolisms, may occur in up to 60% of patients (102).”
BackgroundManagement of neurological complications of infective endocarditis in ICU patients
Sonneville, R., Mourvillier, B., Bouadma, L., & Wolff, M. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-10 · Cited by 82
“Two other studies showed that urgent cardiac surgery in patients with embolic events was feasible with worsening of neurologic status in 6% and 0%, respectively [8,10].”
BackgroundLerche, C. J., Schwartz, F. A., Theut, A. M., Fosbøl, E. L., Iversen, K. K., Bundgaard, H., Høiby, N., & Moser, C. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.643335 · Cited by 86
Misfeld, M., Girrbach, F. F., Etz, C. D., Binner, C., von ASPERN, K., Dohmen, P. M., Davierwala, P. M., Pfannmueller, B., Borger, M. A., & Mohr, F. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.10.076 · Cited by 81
Coronary Embolism: A Systematic Review
Lacey, M. J., Raza, S., Rehman, H., Puri, R., Bhatt, D. L., & Kalra, A. (2019) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2019.05.012 · Cited by 75
Iung, B., Klein, I. F., Mourvillier, B., Olivot, J., Détaint, D., Longuet, P., Ruimy, R., Fourchy, D., Laurichesse, J.-J., Laissy, J., et al. (2012) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jes023 · Cited by 69
Yoshioka, D., Toda, K., Sakaguchi, T., Okazaki, S., Yamauchi, T., Miyagawa, S., Nishi, H., Yoshikawa, Y., Fukushima, S., Saito, T., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezt547 · Cited by 70
Bai, A. D., Agarwal, A., Steinberg, M., Showler, A., Burry, L. D., TOMLINSON, G. A., Bell, C. M., & Morris, A. M. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.04.025 · Cited by 71
Yang, A., Tan, C. E., Daneman, N., Hansen, M. S., Habib, G., Salaün, E., Lavoûte, C., Hubert, S., & Adhikari, N. K. J. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.08.010 · Cited by 66
Value of brain MRI in infective endocarditis: a narrative literature review
Champey, J., Pavèse, P., Bouvaist, H., Kastler, A., Krainik, A., & François, P. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2523-6 · Cited by 68
“aureus etiology is frequently correlated with emboli [10, 21].”
BackgroundImaging investigations in infective endocarditis: Current approach and perspectives
Thuny, F., Gaubert, J., Jacquier, A., Tessonnier, L., Cammilleri, S., Raoult, D., & Habib, G. (2012) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2012.09.004 · Cited by 62
“Although multiple case reports on the use of MRI in identifying valvular and perivalvular damage in patients with IE have been published, this imaging modality seems to be of most value in the identification of silent cerebral complications [26—28,41,42].”
BackgroundWhat is the optimal timing for surgery in infective endocarditis with cerebrovascular complications?
Rossi, M., Gallo, A., Silva, R. J. D., & Sayeed, R. A. (2011) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivr010 · Cited by 55
“…mortality rates were 22, 25 and 38%, respectively, in the CVC group vs. 16, 19 and 31% in the non-CVC group (HR 1.3; 95% CI 0.87–1.91; P = 0.20) Snygg-Martin et al., 2008, Clin Infect Dis, Sweden, [8] Prospective cohort study (level 2a) 60 patients who experienced episodes of left-sided IE…”
BackgroundInfluentialSelton‐Suty, C., Delahaye, F., Tattevin, P., Federspiel, C., Moing, V. L., Chirouze, C., Nazeyrollas, P., Vernet-Garnier, V., Bernard, Y. F., Chocron, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158522 · Cited by 67
“[6] Rates of abnormal findings range from only 4% in asymptomatic patients by CT scan [3] to 65–80% by MRI.[5,9] Highly sensitive MRI sequences found abnormalities in 82% of the patients in the IMAGE study, although only 12% were symptomatic.”
BackgroundNeurological complications of infective endocarditis: New breakthroughs in diagnosis and management
Novy, E., Sonneville, R., Mazighi, M., Klein, I. F., Mariotte, É., Mourvillier, B., Bouadma, L., & Wolff, M. (2013) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2013.09.010 · Cited by 56
Snygg‐Martin, U., Rasmussen, R. V., Hassager, C., Bruun, N. E., Andersson, R., & Olaison, L. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1063-3 · Cited by 53
“Ischaemic stroke with focal neurological symptoms is the most frequently reported cerebral complication in IE but also welldocumented are more complex syndromes with varying combinations of focal neurological signs, meningism and encephalopathy in the same patient, as well as silent cerebral embolism [5, 14, 24, 25].”
BackgroundSelf-citationKlein, M., & Wang, A. (2014) · Journal of Intensive Care Medicine · doi:10.1177/0885066614554906 · Cited by 68
“Other studies have shown that early, urgent cardiac surgery is feasible and safe in patients with IE, recent stroke, and minimal neurologic impairment.(73,74) Likewise, the risk of mortality in those with transient ischemic attacks or asymptomatic neurologic findings demonstrated on CT scan is low and comparable to th…”
Sambola, A., Lozano-Torres, J., Boersma, E. H., Olmos, C., Ternacle, J., Calvo, F., Tribouilloy, C. M., Lukšić, V. R., Hanževački, J. Š., Park, S. W., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad507 · Cited by 52
Okazaki, S., Yoshioka, D., Sakaguchi, M., Sawa, Y., Mochizuki, H., & Kitagawa, K. (2013) · Cerebrovascular Diseases · doi:10.1159/000346101 · Cited by 57
Ferro, J. M., & Fonseca, A. C. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4086-3.00007-2 · Cited by 57
“The risk of embolism is particularly high within the first 2 weeks after diagnosis and decreases in frequency after the beginning of antibiotic therapy (Thuny et al., 2007; Snygg-Martin et al., 2008).”
Infectious Diseases of the Heart: Pathophysiology, Clinical and Imaging Overview
Murillo, H., Restrepo, C. S., Marmol-Velez, A., Vargas, D., Ocazionez, D., Martínez-Jiménez, S., Reddick, R. L., & Baxi, A. J. (2016) · Radiographics · doi:10.1148/rg.2016150225 · Cited by 49
Tam, D. Y., Yanagawa, B., Verma, S., Ruel, M., Fremes, S. E., Mazine, A., Adams, S., & Friedrich, J. O. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.05.010 · Cited by 48
Cimmino, G., Bottino, R., Formisano, T., Orlandi, M., Molinari, D., Sperlongano, S., Castaldo, P., D’Elia, S., Carbone, A., Palladino, A., et al. (2023) · Life · doi:10.3390/life13020377 · Cited by 55
“MR has a higher sensitivity than CT in detecting the cerebral consequences of IE, which are most often ischemic lesions [73,74].”
BackgroundWong, D., Rubinshtein, R., & Keynan, Y. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.07.053 · Cited by 47
“Identification of brain embolization, regardless of symptoms, did not affect timing of valve surgery or predict postoperative neurologic deterioration in 2 studies.(50,51) Conversely, treatment including anticoagulation, antibiotic duration, and surgical intervention was modified on the basis of brain MRI findings in…”
BackgroundStroke Risk Following Infection in Patients with Continuous-Flow Left Ventricular Assist Device
Cho, S., Moazami, N., Katz, S. D., Bhimraj, A., Shrestha, N. K. M., & Frontera, J. A. (2019) · Neurocritical Care · doi:10.1007/s12028-018-0662-1 · Cited by 45
Infective endocarditis in intravenous drug users
Sanaiha, Y., Lyons, R., & Benharash, P. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.11.007 · Cited by 58
Rasmussen, R. V., Snygg-Martin, U., Olaison, L., Buchholtz, K., Larsen, C. T., Hassager, C., & Bruun, N. E. (2009) · Cardiology · doi:10.1159/000235579 · Cited by 41
“In IE patients with major cerebral events, ischaemic stroke or cerebral infections are the most frequent findings, which was also the case in our study. Cerebral haemorrhage is another feared complication often related to haemorrhagic transformation of an ischaemic stroke, acute pyogenic arteritis, or in some cases ru…”
BackgroundSelf-citationS. aureus endocarditis: Clinical aspects and experimental approaches
Hoerr, V., Franz, M., Pletz, M. W., Diab, M., Niemann, S., Faber, C., Doenst, T., Schulze, P. C., Deinhardt‐Emmer, S., & Löffler, B. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2018.02.004 · Cited by 51
Pericart, L., Fauchier, L., Bourguignon, T., Bernard, L., Angoulvant, D., Delahaye, F., Babuty, D., & Bernard, A. B. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.02.010 · Cited by 42
Jiad, E., Gill, S. K., Krutikov, M., Turner, D., Parkinson, M. H., Curtis, C., & Werring, D. J. (2017) · Practical Neurology · doi:10.1136/practneurol-2016-001469 · Cited by 38
Sorabella, R. A., Han, S. M., Grbic, M., Wu, Y. S., Takyama, H., Kurlansky, P. A., Borger, M. A., Argenziano, M., Gordon, R. J., & George, I. (2015) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2015.03.078 · Cited by 34
Infective Endocarditis: A Comprehensive Overview
Kiefer, T. L., & Bashore, T. M. (2012) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0633 · Cited by 35
Long-Term Results After Operations for Active Infective Endocarditis in Native and Prosthetic Valves
Meszaros, K., Nujic, S., Sodeck, G. H., Englberger, L., König, T., Schoenhoff, F., Reineke, D., Roost-Krähenbühl, E., Schmidli, J., Czerny, M., et al. (2012) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2012.04.093 · Cited by 38
“Neurologic events as the most frequent complication in patients with infective endocarditis are strongly correlated with a severe prognosis [14–16].”
BackgroundLee, S., Oh, S.-S., Lim, D.-S., Na, C.-Y., & Kim, J. H. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-30 · Cited by 33
“7% of the patients with IE, which is within the range of 10 to 80% that has been reported in previous studies [2,3,5,13-16].”
BackgroundResultImazio, M. (2024) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001651 · Cited by 37
“…angiography, and the evaluationof infective 28 MRI is particularly helpful in the detection of neurological infective endocarditis have neurological lesions in up to 60 – 80% of cases, 29 mostly ischaemic (50 – 80% of patients) and asymptomatic with a limited impact on the subsequent management.”
BackgroundThuny, F., Habib, G., Dolley, Y. L., Canault, M., Casalta, J., Verdier, M., Aviérinos, J.-F., Raoult, D., Mège, J., Morange, P., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018830 · Cited by 33
“These embolic events (EE) are a frequent and life-threatening complication of IE occurring in 20% to 80% of patients [4,5,6,7,8].”
BackgroundRhodes, H., Hirigoyen, D., Shabnam, L., Williams, D. N., & Hansen, G. T. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000260 · Cited by 32
“No specific data on infectious intracranial cerebral aneurysms (IICAs) were reported (Snygg-Martin et al., 2008).”
Endocarditis and Intravascular Infections
Fowler, V. G., Scheld, W. M., & Bayer, A. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00077-1 · Cited by 38
Utility of Brain Magnetic Resonance Imaging in the Surgical Management of Infective Endocarditis
Chakraborty, T., Scharf, E. L., Rabinstein, A. A., DeSimone, D. C., Rafei, A. E., Brinjikji, W., Baddour, L. M., Wijdicks, E. F. M., Wilson, W. R., Steckelberg, J. M., et al. (2017) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2017.05.047 · Cited by 27
Neurologic Complications of Infective Endocarditis
Pruitt, A. A. (2013) · Current Treatment Options in Neurology · doi:10.1007/s11940-013-0235-8 · Cited by 31
“Although several studies show a high frequency of asymptomatic cerebral embolism by MRI [5, 6], current guidelines do not recommend systematic use of cerebral imaging during acute IE [7].”
BackgroundClinically overt and silent cerebral embolism in the course of infective endocarditis
Grabowski, M., Hryniewiecki, T., Janas, J., & Stępińska, J. (2011) · Journal of Neurology · doi:10.1007/s00415-010-5897-5 · Cited by 29
“Snygg-Martin et al. [ 9 ] used neuroimaging diagnosing (MRI/CT) and showed that cerebral lesions were found in as many as 65% of IE patients, with overt signs of a lesion in the nervous system being diagnosed in only 35% of them.”
BackgroundMethodResultInfluentialD’Anna, L. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04599-9 · Cited by 27
Changes and advances in the field of infective endocarditis
Mills, M. T., Al‐Mohammad, A., & Warriner, D. (2022) · British Journal of Hospital Medicine · doi:10.12968/hmed.2021.0510 · Cited by 51
Snygg-Martin, U., Rasmussen, R. V., Hassager, C., Bruun, N. E., Andersson, R., & Olaison, L. (2011) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2011.603742 · Cited by 25
Self-citationLecomte, R., Issa, N., Gaborit, B. J., Turnier, P. L., Deschanvres, C., Asseray, N., Tourneau, T. L., Michel, M., Habash, O. A., Bizouarn, P., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz014 · Cited by 30
Miura, T., Hamawaki, M., Hazama, S., Hashizume, K., Ariyoshi, T., Sumi, M., Furumoto, A., Saito, N., Tsuneto, A., & Eishi, K. (2014) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-014-0377-y · Cited by 26
Grecu, N., Tiu, C., Terecoasă, E., & Bajenaru, O. A. (2014) · Europe PMC (PubMed Central) · Cited by 34
Targeting Cardiovascular Implant Infection: Multimodality and Molecular Imaging
Sohns, J. M., Bavendiek, U., Ross, T. L., & Bengel, F. M. (2017) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.117.005376 · Cited by 24
Papadimitriou‐Olivgeris, M., Guery, B. P., Ianculescu, N., Dunet, V., Messaoudi, Y., Pistocchi, S., Tozzi, P., Kirsch, M. E. W., & Monney, P. A. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad192 · Cited by 22
“The prevalence of CEEs (39%) among asymptomatic IE patients was significantly higher than previously reported (4%–30%) [4, 5, 8], whereas some studies presented higher rates (60%–80%) [2, 10–14].”
BackgroundResultBacteraemia with gram-positive bacteria—when and how do I need to look for endocarditis?
Rasmussen, M., Gilje, P., Fagman, E., & Berge, A. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.08.027 · Cited by 21
Embolic Events in Infective Endocarditis: A Comprehensive Review
Villalba, G. C., Pulido, P., López, J., de Miguel-Álava, M., Vilacosta, I., García‐Azorín, D., Ibáñez, A. L., Orive, A. O., Arenillas, J. F., & Román, J. A. S. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2503097 · Cited by 27
“Regarding clinically significant EEs, incidence varies widely from 13% to 49% [12,18–20].”
BackgroundLactococcus garvieaeendocarditis presenting with subdural haematoma
Rasmussen, M., Werner, J. B., Dolk, M., & Christensson, B. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-13 · Cited by 24
“Haemorrhages are most often intraparenchymal or subarachnoidal [7-10].”
BackgroundEarly Operation in Patients With Mitral Valve Infective Endocarditis and Acute Stroke Is Safe
Ghoreishi, M., Foster, N., Pasrija, C., Shah, A. M., Watkins, A. C., Evans, C. F., Maghami, S., Quinn, R. W., Wehman, B. P., Taylor, B. S., et al. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.06.069 · Cited by 22
“There is strong accumulating evidence that early MV intervention for IE in the setting of acute stroke is safe and hemorrhagic conversion of an acute infarct is rare [22, 23].”
Anesthesia Considerations in Infective Endocarditis
Hermanns, H., Eberl, S., Terwindt, L. E., Mastenbroek, T. C. B., Bauer, W. O., van der Vaart, T. W., & Preckel, B. (2022) · Anesthesiology · doi:10.1097/aln.0000000000004130 · Cited by 21
“However, when silent cerebral complications are also taken into account, this incidence may reach 65 or even up to 80%.(140,141) The most common complications are ischemic stroke (about 70% of all neurologic complications) and intracranial or subarachnoid hemorrhage (15%), as well as meningitis (5%), brain abscess (5%…”
BackgroundDiab, M., Güenther, A., Sponholz, C., Lehmann, T., Färber, G., Matz, A., Franz, M., Witte, O. W., Pletz, M. W., & Doenst, T. (2016) · Clinical Research in Cardiology · doi:10.1007/s00392-016-0993-x · Cited by 22
Cardiac imaging after ischemic stroke: Echocardiography, CT, or MRI?
Camen, S., Hæusler, K. G., & Schnabel, R. B. (2019) · Herz · doi:10.1007/s00059-019-4803-x · Cited by 23
Vitali, P., Savoldi, F., Segati, F., Melazzini, L., Zanardo, M., Fedeli, M. P., Benedek, A., Leo, G. D., Menicanti, L., & Sardanelli, F. (2021) · Neuroradiology · doi:10.1007/s00234-021-02810-y · Cited by 21
Management of Septic emboli in patients with infectious endocarditis
Aalaei‐Andabili, S. H., Martin, T. D., Hess, P., Hoh, B. L., Anderson, M., Klodell, C. T., & Beaver, T. M. (2017) · Journal of Cardiac Surgery · doi:10.1111/jocs.13129 · Cited by 21
Metadata
- Authors
- Snygg‐Martin, U., Gustafsson, L., Rosengren, L., Alsiö, Å., Ackerholm, P., Andersson, R., & Olaison, L.
- Affiliations
- Sahlgrenska University Hospital (SE)
- Skaraborg Hospital (SE)
- Corresponding author
- Snygg‐Martin, Ulrika
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-07
- Volume
- 47
- Issue
- 1
- Pages
- 23-30
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2151950267
- Semantic Scholar
- 9e3d282e51a4adbb7f90fe1a60c425a6d8f17bd8
- Cited by
- 320
- References
- 41
- Citations by year
- 2026: 1 · 2025: 15 · 2024: 22 · 2023: 15 · 2022: 20 · 2021: 15 · 2020: 22 · 2019: 22 · 2018: 11 · 2017: 21 · 2016: 28 · 2015: 21 · 2014: 27 · 2013: 20 · 2012: 17
- FWCI
- 10.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- infective endocarditis, left-sided endocarditis, cerebrovascular complications, neurofilament proteins, glial fibrillary acidic protein, Staphylococcus aureus, cerebral embolization, cardiac surgery, antibiotic therapy, risk factors
- MeSH terms
- Aged, Anti-Bacterial Agents, Brain, Brain Diseases, Cerebrospinal Fluid, Endocarditis, Female, Glial Fibrillary Acidic Protein, Heart Valves, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Prospective Studies, Radiography, Risk Factors, Staphylococcal Infections, Staphylococcus aureus, Incidence, Neurofilament Proteins, Intracranial Embolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.